LE WE PMID CA
Bone marrow transplantation9Knochenmark (Transplantation)

Anemia (aplastic)

Antineoplastic agents (Novel target ideas)

Autoimmunity

Bone marrow transplantation

BOOP

CNS (Neoplasia Neuroblastoma)

Cyclophosphamide

Graft vs host disease

Graft vs Leukemia Effect

Hemopoiesis (BASKET)

Histone deacetylase

HLA and MHC

Immune reconstitution

Immunotherapy (Adoptive cell transfer)

Kidney (Minimal change nephrotic syndrome)

Krabbe s disease

Leukemia (acute lymphoblastic)

Leukemia (BASKET)

Liver (Veno occlusive disease)

Lung (Diseases)

Lymphoma (BASKET)

Lymphoma (T cell)

Neoplasia (Carcinogenesis)

NK cells

NKT cells

Osteonecrosis (BASKET)

Radioimmunotherapy and radioligandtherapy

Regulatory T cell

Stem cell (Adult somatic derived reprogrammed)

TGF beta

Tolerance (Immunology)

Total body irradiation

Umbilical cord blood

Voriconazole

Wiskott Aldrich syndrome

2003  
1
A systematic review of psychosocial factors affecting survival after bone marrow transplantation.
[12724499] Psychosomatics 44(3): 181-95 (2003)
1997  
2
ABC of clinical haematology. Bone marrow and stem cell transplantation.
[9146394] BMJ 314(7088): 1179-82 (1997)
1995  
3
Bone marrow transplantation.
[7827553] BMJ 310(6971): 31-6 (1995)
1996  
4
Allogeneic bone marrow transplantation.
[8790307] South Med J 89(9): 857-68 (1996)
1976  
5
Skin changes in graft-vs-host disease.
[10632] South Med J 69(10): 1277-81 (1976)
2004  
6
Fulminant liver failure due to severe veno-occlusive disease after haematopoietic cell transplantation: a depressing experience.
[15317927] QJM 97(9): 581-9 (2004)
2009  
7
Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.
[19949725] Korean J Intern Med 24(4): 287-98 (2009)
2002  
8
Allogeneic hematopoietic stem cell transplantation: complications and results.
[12123398] Arch Intern Med 162(14): 1558-66 (2002)
2009  
9
Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention.
[19915226] Neth J Med 67(10): 327-31 (2009)
2005  
10
Reduced-intensity conditioning regimens in malignant haematological diseases.
[15766008] Neth J Med 63(2): 43-51 (2005)
2002  
11
Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
[12164394] Neth J Med 60(4): 162-9 (2002)
2004  
12
Donor bone marrow infusion in deceased and living donor renal transplantation.
[15627290] Yonsei Med J 45(6): 998-1003 (2004)
1998  
13
Bone marrow and peripheral blood stem cell transplantation for malignancy.
[9728295] Health Technol Assess 2(8): 1-187 (1998)
1997  
14
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.
[9105755] Clin Microbiol Rev 10(2): 277-97 (1997)
2005  
15
Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions.
[15958063] Clin Exp Immunol 141(1): 1-9 (2005)
2005  
16
Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).
[16147539] Philos Trans R Soc Lond B Biol Sci 360(1461): 1747-67 (2005)
1992  
17
Marrow transplantation in cancer therapy.
[1306319] Tohoku J Exp Med 168(2): 333-43 (1992)
2007  
18
Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literature.
[16950809] Ann Rheum Dis 66(2): 202-7 (2007)
2001  
19
Haemopoietic stem cell transplantation in the treatment of severe autoimmune diseases 2000.
[11406528] Ann Rheum Dis 60(7): 702-7 (2001)
2008  
20
Stem cell transplantation for rheumatic autoimmune diseases.
[18947373] Arthritis Res Ther 10(5): 217 (2008)
2007  
21
Spectrum of renal pathology in hematopoietic cell transplantation: a series of 20 patients and review of the literature.
[17702721] Clin J Am Soc Nephrol 2(5): 1014-23 (2007)
2006  
22
Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
[17699273] Clin J Am Soc Nephrol 1(4): 685-94 (2006)
2006  
23
Review article: management of hepatic disease following haematopoietic cell transplant.
[16886910] Aliment Pharmacol Ther 24(3): 441-52 (2006)
2008  
24
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.
[18304964] Ann Oncol 19(6): 1082-9 (2008)
2007  
25
Hematopoietic cell transplantation: progress and obstacles.
[17355954] Ann Oncol 18(9): 1450-6 (2007)
2003  
26
Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumors.
[12881372] Ann Oncol 14(8): 1177-84 (2003)
2002  
27
The role of mini-allotransplants in the treatment of solid tumors.
[12401702] Ann Oncol 13 Suppl 4(-): 281-6 (2002)
1996  
28
The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer.
[8646545] CA Cancer J Clin 46(3): 142-64 (1996)
1987  
29
2008  
30
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
[18311781] Cancer 112(9): 1992-2001 (2008)
2004  
31
Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.
[15372473] Cancer 101(9): 1936-46 (2004)
1999  
32
Extramedullary tumors of myeloid blasts in adults as a pattern of relapse following allogeneic bone marrow transplantation.
[10091734] Cancer 85(3): 608-15 (1999)
1998  
33
Neutropenic enterocolitis as a complication of high dose chemotherapy with stem cell rescue in patients with solid tumors: a case series with a review of the literature.
[9690531] Cancer 83(3): 409-14 (1998)
2003  
34
Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review.
[12598853] Cancer Control 10(1): 17-41 (2003)
2002  
35
Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.
[11965233] Cancer Control 9(2): 123-37 (2002)
2004  
36
Nonmyeloablative transplantation: an allogeneic-based immunotherapy for renal cell carcinoma.
[15448030] Clin Cancer Res 10(18 Pt 2): 6353S-9S (2004)
2000  
37
Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations.
[11110600] Oncologist 5(6): 487-96 (2000)
1999  
38
Total-body irradiation in the conditioning regimens for autologous stem cell transplantation in lymphoproliferative diseases.
[10551555] Oncologist 4(5): 386-97 (1999)
1965  
39
Bone marrow transplantation in acute leukemia.
[4955705] Cancer Res 25(9): 1521-4 (1965)
2002  
40
Discontinuation of immunosuppression for prevention of kidney graft rejection after receiving a bone marrow transplant from the same HLA identical sibling donor.
[12447962] Am J Hematol 71(4): 311-3 (2002)
2000  
41
Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.
[10602169] Am J Hematol 63(1): 46-53 (2000)
1998  
42
Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases.
[9423812] Am J Hematol 57(1): 24-8 (1998)
1997  
43
1998  
44
Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation.
[9733265] Bone Marrow Transplant 22(5): 431-7 (1998)
1998  
45
The psychosocial impact of bone marrow transplantation: a review of the literature.
[9733263] Bone Marrow Transplant 22(5): 409-22 (1998)
1998  
46
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation.
[9486487] Bone Marrow Transplant 21(1): 1-7 (1998)
1978  
47
Chronic cutaneous graft-versus-host disease in man.
[26221] Am J Pathol 91(3): 545-70 (1978)
1971  
48
Application of marrow grafts in human disease.
[4399187] Am J Pathol 65(3): 653-68 (1971)
1999  
49
Mechanisms of lung injury after bone marrow transplantation.
[10340926] Am J Respir Cell Mol Biol 20(6): 1097-9 (1999)
2004  
50
Pulmonary complications of solid organ and hematopoietic stem cell transplantation.
[15070821] Am J Respir Crit Care Med 170(1): 22-48 (2004)
1995  
51
Antimicrobial prophylaxis in bone marrow transplantation.
[7598303] Ann Intern Med 123(3): 205-15 (1995)
1994  
52
Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation. A report from the Eastern Cooperative Oncology Group (ECOG)
[8256974] Ann Intern Med 120(2): 143-58 (1994)
1993  
53
Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.
[8391772] Ann Intern Med 119(3): 207-14 (1993)
2005  
54
Haemopoietic stem cell transplantation for genetic disorders.
[16301554] Arch Dis Child 90(12): 1259-63 (2005)
1994  
55
Organ transplantation for inherited metabolic disease.
[7979487] Arch Dis Child 71(3): 181-3 (1994)
1991  
56
Paediatric bone marrow transplantation using donors other than HLA genotypically identical siblings.
[2031621] Arch Dis Child 66(4): 546-50 (1991)
1988  
57
Bone marrow transplantation for leukaemia.
[3046510] Arch Dis Child 63(8): 879-82 (1988)
2005  
58
Hematopoietic stem cell transplantation for multiple sclerosis.
[15956156] Arch Neurol 62(6): 860-4 (2005)
2000  
59
Immune ablation and stem-cell therapy in autoimmune disease. Experimental basis for autologous stem-cell transplantation.
[11094442] Arthritis Res 2(4): 281-4 (2000)
2000  
60
Immune ablation and stem-cell therapy in autoimmune disease. Immunological reconstitution after high-dose immunosuppression and haematopoietic stem-cell transplantation.
[11094440] Arthritis Res 2(4): 270-5 (2000)
2006  
61
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
[17133541] Arthritis Rheum 54(12): 3750-60 (2006)
2006  
62
Hematopoietic stem cell transplantation in autoimmune diseases: is the glass half full or half empty?
[17133534] Arthritis Rheum 54(12): 3730-4 (2006)
2004  
63
Nonmyeloablative allogeneic hematopoietic stem cell transplantation for autoimmune disease.
[15334449] Arthritis Rheum 50(8): 2387-90 (2004)
2008  
64
Graft-versus-leukemia effects of transplantation and donor lymphocytes.
[19029455] Blood 112(12): 4371-83 (2008)
2008  
65
The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.
[18948588] Blood 112(9): 3543-53 (2008)
2008  
66
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges.
[18057230] Blood 111(4): 1767-72 (2008)
2007  
67
How I treat refractory acute GVHD.
[17234737] Blood 109(10): 4119-26 (2007)
2007  
68
Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation.
[17008540] Blood 109(4): 1355-62 (2007)
2006  
69
Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL?
[16380448] Blood 107(9): 3430-5 (2006)
2005  
70
New approaches for preventing and treating chronic graft-versus-host disease.
[15701727] Blood 105(11): 4200-6 (2005)
2005  
71
New trends in umbilical cord blood transplantation.
[15677563] Blood 105(10): 3786-92 (2005)
2004  
72
Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature.
[15280195] Blood 104(10): 3400-7 (2004)
2004  
73
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy.
[14644993] Blood 103(6): 2003-8 (2004)
2004  
74
Graft-versus-leukemia reactions in allogeneic chimeras.
[12958064] Blood 103(3): 767-76 (2004)
2003  
75
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis.
[12920027] Blood 102(13): 4290-7 (2003)
2003  
76
Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants.
[12869516] Blood 102(10): 3822-8 (2003)
2003  
77
Nonmalignant late effects after allogeneic stem cell transplantation.
[12511420] Blood 101(9): 3373-85 (2003)
2002  
78
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
[12393596] Blood 100(13): 4344-50 (2002)
2001  
79
How I treat chronic graft-versus-host disease.
[11222360] Blood 97(5): 1196-201 (2001)
1999  
80
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
[10477676] Blood 94(5): 1517-36 (1999)
1998  
81
Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation.
[9716573] Blood 92(5): 1471-90 (1998)
1998  
82
Treatment of severe veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high-risk population.
[9680339] Blood 92(3): 737-44 (1998)
1998  
83
Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
[9490664] Blood 91(6): 1833-44 (1998)
1997  
84
Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation.
[9389681] Blood 90(12): 4665-78 (1997)
1997  
85
Allogeneic blood stem cell transplantation: considerations for donors.
[9242518] Blood 90(3): 903-8 (1997)
1997  
86
Autologous transplantation therapy for chronic myelogenous leukemia.
[9108379] Blood 89(8): 2623-34 (1997)
1997  
87
The biology and clinical uses of blood stem cells.
[9116266] Blood 89(7): 2233-58 (1997)
1997  
88
Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients.
[9057629] Blood 89(5): 1501-6 (1997)
1996  
89
Biologic and clinical effects of granulocyte colony-stimulating factor in normal individuals.
[8874177] Blood 88(8): 2819-25 (1996)
1996  
90
Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics.
[8605320] Blood 87(8): 3082-8 (1996)
1995  
91
Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.
[7579369] Blood 86(10): 3979-86 (1995)
1995  
92
Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation.
[7606012] Blood 86(2): 813-8 (1995)
1995  
93
Treatment of Chediak-Higashi syndrome by allogenic bone marrow transplantation: report of 10 cases.
[7756666] Blood 85(11): 3328-33 (1995)
1995  
94
Bone marrow transplantation in major histocompatibility complex class II deficiency: a single-center study of 19 patients.
[7812013] Blood 85(2): 580-7 (1995)
1995  
95
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients.
[7529066] Blood 85(2): 588-96 (1995)
1994  
96
Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency.
[7949150] Blood 84(11): 3936-47 (1994)
1994  
97
A special report: bone marrow transplants using volunteer donors--recommendations and requirements for a standardized practice throughout the world--1994 update. The WMDA Executive Committee.
[7949160] Blood 84(9): 2833-9 (1994)
1994  
98
Graft-versus-host disease: new directions for a persistent problem.
[7919322] Blood 84(7): 2061-7 (1994)
1994  
99
Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: where do we stand?
[8167329] Blood 83(9): 2392-8 (1994)
1994  
100
Hematopoietic recovery after 10-Gy acute total body radiation.
[8286754] Blood 83(2): 596-9 (1994)
1993  
101
Graft-versus-leukemia: no longer an epiphenomenon.
[8400279] Blood 82(8): 2273-7 (1993)
1993  
102
Preparative regimens for autologous bone marrow transplantation.
[8422454] Blood 81(2): 277-80 (1993)
1992  
103
Conditioning for allogeneic marrow transplantation in patients with lymphohematopoietic malignancies without the use of total body irradiation.
[1391935] Blood 80(7): 1648-58 (1992)
1992  
104
Bone marrow transplantation for thalassemia and other inherited disorders of hemoglobin.
[1520865] Blood 80(6): 1379-81 (1992)
1992  
105
Determinants of engraftment after allogeneic marrow transplantation.
[1558962] Blood 79(7): 1647-50 (1992)
1990  
106
Minor histocompatibility antigens.
[2207305] Blood 76(7): 1269-80 (1990)
1990  
107
Indications for marrow transplantation in acute lymphoblastic leukemia.
[2405919] Blood 75(4): 815-8 (1990)
1989  
108
Bone marrow transplantation in the treatment of patients with lymphoma.
[2653463] Blood 73(7): 1749-58 (1989)
1987  
109
The kinetics of immune reconstitution after human marrow transplantation.
[3542077] Blood 69(2): 369-80 (1987)
1983  
110
Allogenic bone marrow transplantation: current status and future directions.
[6354307] Blood 62(5): 941-64 (1983)
1977  
111
Current status of bone marrow transplantation for aplastic anemia and acute leukemia.
[15688] Blood 49(5): 671-81 (1977)
1957  
112
Experimental treatment of total-body irradiation injury: a brief review.
[13446002] Blood 12(8): 746-54 (1957)
1997  
113
Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT).
[9133976] Br J Rheumatol 36(3): 390-2 (1997)
1983  
114
Acute graft-versus-host disease after allogeneic bone marrow transplantation.
[6367917] Can Med Assoc J 129(9): 969-74 (1983)
1973  
115
Editorial: Bone-marrow transplants for immunodeficiency syndromes.
[4147519] Can Med Assoc J 109(7): 569 (1973)
2003  
116
Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children.
[12907557] Chest 124(2): 660-4 (2003)
2001  
117
Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance.
[11591544] Chest 120(4): 1094-100 (2001)
1996  
118
Pulmonary complications of bone marrow transplantation.
[8635332] Chest 109(4): 1066-77 (1996)
1985  
119
Pulmonary complications of bone marrow transplantation.
[2981658] Chest 87(2): 237-46 (1985)
2007  
120
Bronchiolitis obliterans following haematopoietic stem cell transplantation.
[17470622] Eur Respir J 29(5): 1007-19 (2007)
2005  
121
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
[15738280] Eur Respir J 25(3): 402-4 (2005)
2004  
122
Reduced intensity conditioning before allografting: moderate enthusiasm may be more appropriate.
[15065819] Eur Respir J 23(3): 357-8 (2004)
2009  
123
Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.
[19648165] Haematologica 94(12): 1732-42 (2009)
2009  
124
Cord blood transplantation: state of the art.
[19336748] Haematologica 94(4): 451-4 (2009)
2008  
125
Allogeneic stem cell transplantation for thalassemia major.
[19050069] Haematologica 93(12): 1780-4 (2008)
2008  
126
Allogeneic transplantation in multiple myeloma.
[18757850] Haematologica 93(9): 1295-300 (2008)
2008  
127
Hematopoietic stem cell mobilization.
[18310535] Haematologica 93(3): 321-4 (2008)
2007  
128
Allogeneic transplantation in lymphoma: current status.
[18024402] Haematologica 92(11): 1533-48 (2007)
2007  
129
Post-transplant lymphoproliferative disorders: from treatment to early detection and prevention?
[18024391] Haematologica 92(11): 1447-50 (2007)
2007  
130
Current status of reduced-intensity-conditioning allogeneic stem cell transplantation for acute myeloid leukemia.
[17488664] Haematologica 92(4): 533-41 (2007)
2006  
131
Spontaneous splenic rupture in a healthy allogeneic donor of peripheral-blood stem cell following the administration of granulocyte colony-stimulating factor (g-csf). A case report and review of the literature.
[16709516] Haematologica 91(5 Suppl): ECR08 (2006)
2006  
132
Strategies for widening the use of cord blood in hematopoietic stem cell transplantation.
[16670062] Haematologica 91(5): 584-7 (2006)
2004  
133
Allogeneic hematopoietic stem cell transplantation for metastatic breast cancer.
[15136224] Haematologica 89(5): 599-605 (2004)
2004  
134
Expansion of cord blood hematopoietic stem cells for clinical application.
[15020261] Haematologica 89(3): 263 (2004)
2003  
135
Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia.
[12745266] Haematologica 88(5): 484-6 (2003)
2003  
136
Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen.
[12651288] Haematologica 88(3): ELT06 (2003)
2003  
137
Stem cell transplantation for patients with solid tumors.
[12604400] Haematologica 88(2): 124-5 (2003)
2002  
138
Are we sure we all do the same things? Results from a GITMO survey on basic practices in allogeneic bone marrow transplantation.
[12010654] Haematologica 87(5): 449-52 (2002)
2000  
139
Oupatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation.
[11114127] Haematologica 85(12): 1233-4 (2000)
2000  
140
Low intensity regimens with allogeneic hematopoietic stem cell transplantation as treatment of hematologic neoplasia.
[10702821] Haematologica 85(3): 304-13 (2000)
2000  
141
Allogeneic bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
[10627666] Haematologica 85(1): 1-2 (2000)
1999  
142
Autologous and allogeneic transplantation with peripheral blood CD34+ cells: a pediatric experience.
[10091416] Haematologica 84(2): 167-76 (1999)
1999  
143
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
[10091394] Haematologica 84(1): 71-9 (1999)
1999  
144
Bone marrow transplantation for severe aplastic anemia from HLA identical siblings.
[10091385] Haematologica 84(1): 2-4 (1999)
1998  
145
Allogeneic hematopoietic stem cell transplantation after immunosuppressive but non-myeloablative conditioning: "miniallografts" are no small matter.
[9830793] Haematologica 83(10): 865-7 (1998)
1998  
146
Ex vivo expansion of hematopoietic cells and their clinical use.
[9825579] Haematologica 83(9): 824-48 (1998)
1998  
147
Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.
[9549928] Haematologica 83(2): 159-82 (1998)
1997  
148
The veno-occlusive disease of the liver.
[9499675] Haematologica 82(6): 718-25 (1997)
1997  
149
Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
[9175330] Haematologica 82(2): 220-38 (1997)
1996  
150
Stem cells and stem cell transplantation.
[9009446] Haematologica 81(6): 573-87 (1996)
1996  
151
Peripheral blood stem cell transplantation for the treatment of multiple myeloma: biological and clinical implications.
[8870384] Haematologica 81(4): 356-75 (1996)
1995  
152
CD34-positive cells: biology and clinical relevance.
[7590508] Haematologica 80(4): 367-87 (1995)
2009  
153
ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?
[20008227] Hematology Am Soc Hematol Educ Program -(-): 414-8 (2009)
2008  
154
Recognizing and managing chronic graft-versus-host disease.
[19074071] Hematology Am Soc Hematol Educ Program -(-): 134-41 (2008)
2008  
155
Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices.
[19074070] Hematology Am Soc Hematol Educ Program -(-): 125-33 (2008)
2007  
156
Follicular NHL: from antibodies and vaccines to graft-versus-lymphoma effects.
[18024634] Hematology Am Soc Hematol Educ Program -(-): 226-32 (2007)
2007  
157
Diagnosis, genetics, and management of inherited bone marrow failure syndromes.
[18024606] Hematology Am Soc Hematol Educ Program (): 29-39 (2007)
2006  
158
Vaccine-enhanced donor lymphocyte infusion (veDLI).
[17124103] Hematology Am Soc Hematol Educ Program -(-): 486-91, 513 (2006)
2006  
159
Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies.
[17124089] Hematology Am Soc Hematol Educ Program -(-): 398-401 (2006)
2006  
160
Reduced-intensity regimens in allogeneic stem-cell transplantation for non-hodgkin lymphoma and chronic lymphocytic leukemia.
[17124088] Hematology Am Soc Hematol Educ Program -(-): 390-7 (2006)
2006  
161
Managing the patient with chronic myeloid leukemia through and after allogeneic stem cell transplantation.
[17124065] Hematology Am Soc Hematol Educ Program -(-): 226-32 (2006)
2004  
162
Stem cell transplantation (cord blood transplants).
[15561692] Hematology Am Soc Hematol Educ Program -(-): 354-71 (2004)
2004  
163
2003  
164
2003  
165
2003  
166
Realistic prospects for stem cell therapeutics.
[14633792] Hematology Am Soc Hematol Educ Program -(-): 398-418 (2003)
2003  
167
Hematopoietic cell transplantation for benign hematological disorders and solid tumors.
[14633791] Hematology Am Soc Hematol Educ Program -(-): 372-97 (2003)
2003  
168
New developments in allotransplant immunology.
[14633790] Hematology Am Soc Hematol Educ Program -(-): 350-71 (2003)
2002  
169
Stem cell transplantation: supportive care and long-term complications.
[12446435] Hematology Am Soc Hematol Educ Program -(-): 422-44 (2002)
2002  
170
2001  
171
Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
[11722995] Hematology Am Soc Hematol Educ Program -(-): 392-421 (2001)
2001  
172
Non-myeloablative transplants for malignant disease.
[11722994] Hematology Am Soc Hematol Educ Program -(-): 375-91 (2001)
1998  
173
Allogeneic peripheral blood stem cell transplantation as an alternative to allogeneic bone marrow transplantation.
[9932627] Intern Med 37(12): 1001-2 (1998)
1996  
174
Late onset bone marrow transplant nephropathy.
[8835602] Intern Med 35(6): 489-93 (1996)
2002  
175
Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support.
[12455162] Isr Med Assoc J 4(11 Suppl): 865-7 (2002)
2002  
176
Stem-cell transplantation for primary immunodeficiencies.
[12183876] Isr Med Assoc J 4(8): 648-52 (2002)
2002  
177
Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders.
[12001702] Isr Med Assoc J 4(4): 272-9 (2002)
2002  
178
Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases.
[12001701] Isr Med Assoc J 4(4): 268-71 (2002)
2006  
179
Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment.
[16723390] J Am Soc Nephrol 17(7): 1995-2005 (2006)
1997  
180
Bone marrow transplant nephropathy: a case report and review of the literature.
[9013462] J Am Soc Nephrol 8(1): 166-73 (1997)
1983  
181
A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia.
[6355192] J Clin Pathol 36(11): 1207-14 (1983)
1970  
182
Animal models for bone-marrow transplantation.
[4396089] J Med Genet 7(4): 305-9 (1970)
2009  
183
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
[19509382] JAMA 301(22): 2349-61 (2009)
2008  
184
Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases.
[18314435] JAMA 299(8): 925-36 (2008)
2008  
185
Biology of chronic graft-versus-host disease: implications for a future therapeutic approach.
[19110529] Keio J Med 57(4): 177-83 (2008)
2003  
186
Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders.
[12911046] Mayo Clin Proc 78(8): 981-90 (2003)
2003  
187
Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
[12744547] Mayo Clin Proc 78(5): 589-98 (2003)
2007  
188
Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
[17255123] Nephrol Dial Transplant 22(5): 1369-76 (2007)
2005  
189
Comparison of renal injury in myeloablative autologous, myeloablative allogeneic and non-myeloablative allogeneic haematopoietic cell transplantation.
[15741210] Nephrol Dial Transplant 20(4): 678-83 (2005)
1996  
190
Haemolytic uraemic syndrome following bone marrow transplantation. Case report and review of the literature.
[8672033] Nephrol Dial Transplant 11(7): 1332-7 (1996)
2007  
191
Acute graft versus host disease.
[17784964] Orphanet J Rare Dis 2(-): 35 (2007)
2006  
192
A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation.
[16923928] Pediatrics 118(3): e879-89 (2006)
2002  
193
Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients.
[11986464] Pediatrics 109(5): 965-71 (2002)
2002  
194
Non-infectious pulmonary complications after bone marrow transplantation.
[12151565] Postgrad Med J 78(919): 257-62 (2002)
2006  
195
Autologous haematopoeitic stem cell rescue (AHSCR) for severe rheumatic disease in children: guidance for BSPAR members--executive summary.
[17077155] Rheumatology (Oxford) 45(12): 1570-1 (2006)
2001  
196
Allogeneic haematopoietic stem cell transplantation with reduced intensity conditioning regimens ("minitransplants").
[11383226] Swiss Med Wkly 131(5-6): 59-64 (2001)
1986  
197
Bone marrow transplantation and the lung.
[3538482] Thorax 41(7): 497-502 (1986)
1990  
198
Bone marrow transplantation. Part II--autologous.
[2408234] West J Med 152(1): 46-51 (1990)
1989  
199
Bone marrow transplantation. Part I--Allogeneic.
[2694621] West J Med 151(6): 638-43 (1989)
1989  
200
Bone marrow transplantation.
[2487998] West J Med 151(6): 658-9 (1989)
1994  
201
Acute renal failure in the setting of bone marrow transplantation.
[7853806] Kidney Int 46(5): 1443-58 (1994)
2005  
202
Non-infectious manifestations of stem cell transplantation.
[15730997] Br J Radiol 78(927): 272-81 (2005)
2003  
203
Pulmonary complications following bone marrow transplantation.
[12814922] Br J Radiol 76(906): 373-9 (2003)
2001  
204
Total body irradiation using a modified standing technique: a single institution 7 year experience.
[11709470] Br J Radiol 74(887): 1041-7 (2001)
1997  
205
The radiobiological basis of total body irradiation.
[9505837] Br J Radiol 70(840): 1204-7 (1997)
1997  
206
Total body irradiation. Report on a meeting organized by the BIR Oncology Committee, held at The Royal Institute of British Architects, London, 28 November 1996.
[9505836] Br J Radiol 70(840): 1201-3 (1997)
2008  
207
CT of gastrointestinal complications associated with hematopoietic stem cell transplantation.
[18287443] AJR Am J Roentgenol 190(3): 712-9 (2008)
2005  
208
Pulmonary infections after bone marrow transplantation: high-resolution CT findings in 111 patients.
[16120907] AJR Am J Roentgenol 185(3): 608-15 (2005)
2005  
209
High-resolution CT and pathologic findings of noninfectious pulmonary complications after hematopoietic stem cell transplantation.
[15671389] AJR Am J Roentgenol 184(2): 629-37 (2005)
2007  
210
Imaging the complications of bone marrow transplantation in children.
[17374855] Radiographics 27(2): 307-24 (2007)
2005  
211
Imaging evaluation of pulmonary and abdominal complications following hematopoietic stem cell transplantation.
[15798050] Radiographics 25(2): 305-17; discussion 318 (2005)
1990  
212
An overview of bone marrow transplantation for chronic myeloid leukemia.
[2199009] CMAJ 143(3): 187-93 (1990)
1997  
213
Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings.
[9397451] Radiographics 17(6): 1359-71 (1997)
1993  
214
Abdominal complications in pediatric bone marrow transplant recipients.
[8210593] Radiographics 13(5): 1101-12 (1993)
1991  
215
Bone marrow transplantation: clinical and radiologic aspects.
[1887115] Radiographics 11(4): 601-10 (1991)
2009  
216
CNS complications of hematopoietic stem cell transplantation.
[19304707] AJR Am J Roentgenol 192(4): 1003-11 (2009)
2009  
217
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens.
[19561323] Blood 114(9): 1729-35 (2009)
2008  
218
A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.
[18583566] Blood 112(8): 3036-47 (2008)
2008  
219
Cardiovascular disease after hematopoietic cell transplantation--lessons learned.
[18669977] Haematologica 93(8): 1132-6 (2008)
2006  
220
Viral hepatitis: manifestations and management strategy.
[17124086] Hematology Am Soc Hematol Educ Program -(-): 375-80 (2006)
2010  
221
Hematologic disorders after solid organ transplantation.
[21239807] Hematology Am Soc Hematol Educ Program 2010(-): 281-6 (2010)
2010  
222
Long-term physiological side effects after allogeneic bone marrow transplantation.
[21239799] Hematology Am Soc Hematol Educ Program 2010(-): 229-36 (2010)
2008  
223
Osteonecrosis after allogeneic bone marrow transplantation.
[18196408] Clin Orthop Relat Res 466(2): 287-93 (2008)
2005  
224
Topics in pediatric leukemia--hematopoietic stem cell transplantation.
[16369324] MedGenMed 7(1): 19 (2005)
2011  
225
Progress in hematopoietic cell transplantation.
[21976239] Cancer Control 18(4): 212-3 (2011)
2011  
226
Umbilical cord blood transplantation for the treatment of hematologic malignancies.
[21976241] Cancer Control 18(4): 222-36 (2011)
2011  
227
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation in adults with acute myeloid leukemia.
[21976242] Cancer Control 18(4): 237-45 (2011)
2011  
228
Hematopoietic cell transplantation for lymphomas.
[21976243] Cancer Control 18(4): 246-57 (2011)
2011  
229
Graft-vs-host disease following allogeneic hematopoietic cell transplantation.
[21976245] Cancer Control 18(4): 268-76 (2011)
2003  
230
Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review.
[12598856] Cancer Control 10(1): 57-65 (2003)
2007  
231
The diagnosis, management, and role of hematopoietic stem cell transplantation in aggressive peripheral T-cell neoplasms.
[17387300] Cancer Control 14(2): 151-9 (2007)
2011  
232
HDAC inhibition and graft versus host disease.
[21298214] Mol Med 17(5-6): 404-16 (2011)
2011  
233
Allogeneic adoptive cell transfer therapy as a potent universal treatment for cancer.
[21719916] Oncotarget 2(7): 525-6 (2011)
2008  
234
New advances in hematopoietic cell transplantation.
[18832924] Curr Opin Hematol 15(6): 549-54 (2008)
2009  
235
Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update.
[19812489] Curr Opin Hematol 16(6): 460-5 (2009)
2010  
236
Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.
[19766729] Biol Blood Marrow Transplant 16(2): 157-68 (2010)
2010  
237
Long-term consequences of hematopoietic stem cell transplantation: current state of the science.
[19782145] Biol Blood Marrow Transplant 16(1 Suppl): S90-6 (2010)
2010  
238
Immune reconstitution: how it should work, what's broken, and why it matters.
[19819340] Biol Blood Marrow Transplant 16(1 Suppl): S133-7 (2010)
2010  
239
Bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation-an increasingly recognized manifestation of chronic graft-versus-host disease.
[19896545] Biol Blood Marrow Transplant 16(1 Suppl): S106-14 (2010)
2010  
240
Hepatic safety of voriconazole after allogeneic hematopoietic stem cell transplantation.
[20053331] Biol Blood Marrow Transplant 16(1): 46-52 (2010)
2009  
241
Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility?
[19285632] Biol Blood Marrow Transplant 15(4): 447-53 (2009)
2009  
242
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses.
[19539207] Biol Blood Marrow Transplant 15(7): 765-76 (2009)
2008  
243
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
[18275894] Biol Blood Marrow Transplant 14(3): 282-9 (2008)
2008  
244
2010  
245
Transplant outcomes in acute leukemia. I.
[20109611] Semin Hematol 47(1): 46-50 (2010)
2008  
246
Radioimmunotherapy-based conditioning regimens for stem cell transplantation.
[18381107] Semin Hematol 45(2): 118-25 (2008)
2010  
247
How closely related is graft-vs-leukemia to donor/recipient disparity?
[21130417] Best Pract Res Clin Haematol 23(4): 525-8 (2010)
2009  
248
High-resolution typing for unrelated donor transplantation: how far do we go?
[19959105] Best Pract Res Clin Haematol 22(4): 537-41 (2009)
2008  
249
Immune reconstitution and implications for immunotherapy following haematopoietic stem cell transplantation.
[18790456] Best Pract Res Clin Haematol 21(3): 579-96 (2008)
2008  
250
Post-transplant adoptive T-cell immunotherapy.
[18790452] Best Pract Res Clin Haematol 21(3): 503-19 (2008)
2010  
251
Allogeneic hematopoietic cell transplantation: the state of the art.
[20871781] Expert Rev Hematol 3(3): 285-99 (2010)
2007  
252
Minimal change nephrotic syndrome after stem cell transplantation: a case report and literature review.
[17971194] J Med Case Reports 1(-): 121 (2007)
2008  
253
Gastrointestinal complications following hematopoietic stem cell transplantation in children.
[18838855] Korean J Radiol 9(5): 449-57 (2008)
2008  
254
Enhancing T cell reconstitution after hematopoietic stem cell transplantation: a brief update of the latest trends.
[17905611] Blood Cells Mol Dis 40(1): 44-7 (2008)
2008  
255
Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review.
[17884641] Blood Cells Mol Dis 40(1): 20-4 (2008)
2008  
256
Rebuilding immunity in cancer patients.
[17827037] Blood Cells Mol Dis 40(1): 94-100 (2008)
2010  
257
Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.
[20381970] Cancer Treat Rev 36(7): 528-38 (2010)
2010  
258
Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD.
[19684623] Bone Marrow Transplant 45(4): 662-7 (2010)
2008  
259
Stem cell transplantation for neuroblastoma.
[18037943] Bone Marrow Transplant 41(2): 159-65 (2008)
2010  
260
Hematopoietic stem cell transplantation for leukemia.
[20307709] Pediatr Clin North Am 57(1): 1-25 (2010)
2009  
261
Non-myeloablative allogeneic hematopoietic stem cell transplantation.
[19411015] Semin Oncol Nurs 25(2): 120-8 (2009)
2010  
262
Development of a health-related website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS.
[19967409] J Cancer Surviv 4(1): 67-73 (2010)
2010  
263
Advances in cord blood transplants in adults.
[20948874] F1000 Med Rep 2(-): - (2010)
2010  
264
Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.
[20493393] Immunol Allergy Clin North Am 30(2): 159-71 (2010)
2010  
265
Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.
[20493395] Immunol Allergy Clin North Am 30(2): 179-94 (2010)
2010  
266
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation.
[20066512] Immunol Res 47(1-3): 65-77 (2010)
2010  
267
Reconstitution of self-tolerance after hematopoietic stem cell transplantation.
[20066509] Immunol Res 47(1-3): 143-52 (2010)
2010  
268
NKT cells, Treg, and their interactions in bone marrow transplantation.
[20583031] Eur J Immunol 40(7): 1862-9 (2010)
2010  
269
Pleiotropic effects of transforming growth factor-beta in hematopoietic stem-cell transplantation.
[20671593] Transplantation 90(11): 1139-44 (2010)
2010  
270
Mobilization strategies in hard-to-mobilize patients with lymphoid malignancies.
[20738393] Eur J Haematol 85(6): 463-71 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: bone marrow transplantation
GG: bmt
GG: stem cell transplantation

  • Knochenmark (Transplantation)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia